These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
709 related items for PubMed ID: 30706816
1. Design, Synthesis, Evaluation of Antimicrobial Activity and Docking Studies of New Thiazole-based Chalcones. Tratrat C, Haroun M, Xenikakis I, Liaras K, Tsolaki E, Eleftheriou P, Petrou A, Aldhubiab B, Attimarad M, Venugopala KN, Harsha S, Elsewedy HS, Geronikaki A, Soković M. Curr Top Med Chem; 2019; 19(5):356-375. PubMed ID: 30706816 [Abstract] [Full Text] [Related]
2. Novel chalcone-conjugated, multi-flexible end-group coumarin thiazole hybrids as potential antibacterial repressors against methicillin-resistant Staphylococcus aureus. Hu Y, Hu C, Pan G, Yu C, Ansari MF, Yadav Bheemanaboina RR, Cheng Y, Zhou C, Zhang J. Eur J Med Chem; 2021 Oct 15; 222():113628. PubMed ID: 34139627 [Abstract] [Full Text] [Related]
3. Thiazole-Based Thiazolidinones as Potent Antimicrobial Agents. Design, Synthesis and Biological Evaluation. Haroun M, Tratrat C, Tsolaki E, Geronikaki A. Comb Chem High Throughput Screen; 2016 Oct 15; 19(1):51-7. PubMed ID: 26632442 [Abstract] [Full Text] [Related]
9. New Caffeic Acid Derivatives as Antimicrobial Agents: Design, Synthesis, Evaluation and Docking. Merlani M, Barbakadze V, Amiranashvili L, Gogilashvili L, Poroikov V, Petrou A, Geronikaki A, Ciric A, Glamoclija J, Sokovic M. Curr Top Med Chem; 2019 Jan 15; 19(4):292-304. PubMed ID: 30674263 [Abstract] [Full Text] [Related]
10. 5-Adamantan thiadiazole-based thiazolidinones as antimicrobial agents. Design, synthesis, molecular docking and evaluation. Fesatidou M, Zagaliotis P, Camoutsis C, Petrou A, Eleftheriou P, Tratrat C, Haroun M, Geronikaki A, Ciric A, Sokovic M. Bioorg Med Chem; 2018 Sep 01; 26(16):4664-4676. PubMed ID: 30107969 [Abstract] [Full Text] [Related]
11. Thiazole-based chalcones as potent antimicrobial agents. Synthesis and biological evaluation. Liaras K, Geronikaki A, Glamočlija J, Cirić A, Soković M. Bioorg Med Chem; 2011 May 15; 19(10):3135-40. PubMed ID: 21524583 [Abstract] [Full Text] [Related]
12. Design, synthesis and antibacterial activity studies of thiazole derivatives as potent ecKAS III inhibitors. Cheng K, Xue JY, Zhu HL. Bioorg Med Chem Lett; 2013 Jul 15; 23(14):4235-8. PubMed ID: 23731945 [Abstract] [Full Text] [Related]
13. New Benzothiazole-based Thiazolidinones as Potent Antimicrobial Agents. Design, synthesis and Biological Evaluation. Haroun M, Tratrat C, Kositsi K, Tsolaki E, Petrou A, Aldhubiab B, Attimarad M, Harsha S, Geronikaki A, Venugopala KN, Elsewedy HS, Sokovic M, Glamoclija J, Ciric A. Curr Top Med Chem; 2018 Jul 15; 18(1):75-87. PubMed ID: 29412109 [Abstract] [Full Text] [Related]
14. Novel 1,2,4-oxadiazole-chalcone/oxime hybrids as potential antibacterial DNA gyrase inhibitors: Design, synthesis, ADMET prediction and molecular docking study. Ibrahim TS, Almalki AJ, Moustafa AH, Allam RM, Abuo-Rahma GEA, El Subbagh HI, Mohamed MFA. Bioorg Chem; 2021 Jun 15; 111():104885. PubMed ID: 33838559 [Abstract] [Full Text] [Related]
15. Synthesis and antibacterial evaluation of a novel series of synthetic phenylthiazole compounds against methicillin-resistant Staphylococcus aureus (MRSA). Mohammad H, Reddy PV, Monteleone D, Mayhoub AS, Cushman M, Seleem MN. Eur J Med Chem; 2015 Apr 13; 94():306-16. PubMed ID: 25771109 [Abstract] [Full Text] [Related]
17. Identification of 5,6-dihydroimidazo[2,1-b]thiazoles as a new class of antimicrobial agents. Li Y, Bionda N, Fleeman R, Wang H, Ozawa A, Houghten RA, Shaw L. Bioorg Med Chem; 2016 Nov 01; 24(21):5633-5638. PubMed ID: 27663549 [Abstract] [Full Text] [Related]